MREO Earnings & Financial Statements - Mereo BioPharma Group plc logo

MREO Earnings & Financial Statements

Mereo BioPharma Group plc

$0.26
-$0.02(-5.45%)
38
Overall
60
Value
27
Tech
28
Quality
How is this score calculated?
Market Cap
$43.92M
Volume
1.09M
52W Range
$0.20 - $0.78
Target Price
$1.75

MREO earnings and financial statements: Mereo BioPharma Group plc's income statement, balance sheet and cash flow statement, annual and quarterly.

MREO Annual Financial Statements

MREO income statement
Fiscal year20262025202520252024
Revenue-$800.0K$300.0K--
Cost of revenue-$133.0K---
Operating income-$8.77M-$40.11M-$10.02M-$11.20M-$47.36M
EBITDA-$6.39M-$40.47M-$7.00M-$6.91M-$42.38M
Net income-$6.72M-$41.88M-$7.02M-$7.36M-$44.84M
EPS (diluted)---$-0.10$-0.30
MREO balance sheet
Fiscal year20262025202520252024
Total assets$40.61M$45.92M$53.60M$68.32M$76.39M
Total liabilities$6.56M$5.00M$7.00M$8.24M$15.42M
Shareholders’ equity$34.05M$40.92M$46.60M$60.08M$60.97M
Cash and equivalents$36.22M$40.99M$48.70M$62.48M$69.80M
Long-term debt----$187.0K
MREO cash flow statement
Fiscal year20262025202520252024
Operating cash flow-$4.31M-$30.97M-$23.29M-$8.33M-$32.83M
Free cash flow-$4.61M-$31.29M-$23.61M-$8.65M-$33.53M
ABCD
1SymbolPriceChangeVol
2MREO$0.26-5.5%1.09M
3
4
5
6

Get Mereo BioPharma Group plc Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.